IDInês Dias

Inês Dias

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Inês Dias has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Beatriz Serambeque

    Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, 3000-548 Coimbra, Portugal

    3 shared publications
  • Mafalda Laranjo

    Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, 3000-548 Coimbra, Portugal

    3 shared publications
  • Maria Filomena Botelho

    Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal

    3 shared publications
  • Carlos Miguel Marto

    Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal

    2 shared publications
  • Maria João Carvalho

    Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, 3000-548 Coimbra, Portugal

    2 shared publications
  • Ana Cristina Gonçalves

    Univ Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), 3000-548 Coimbra, Portugal

    1 shared publication

Latest Publications

  • Open Access

    The role of biomaterials in ovarian tissue cryopreservation and transplantation: a scoping review

    by Inês Dias, Gabriela Correia-Barros, Carlos Miguel Marto, Beatriz Serambeque, Maria Filomena Botelho, Teresa Almeida Santos, Ana Sofia Pais, Mafalda Laranjo

    Fertility preservation for women undergoing gonadotoxic treatments remains a critical clinical challenge. Ovarian tissue (OT) cryopreservation and transplantation are promising strategies. This review aims to map the biomaterials used in OT culture and cryopreservation, identify key knowledge gaps, and outline future research directions. Following the Arksey & O’Malley’s (2005) framework and the PRISMA-ScR guidelines, a literature search was conducted on PubMed and Web of Science. The review protocol was prospectively registered on the Open Science Framework (OSF.IO/NRZM7). Of 3217 studies, 41 were included in the analysis: 32 were in vivo studies, 8 were in vitro , and 1 was clinical. The main biomaterials used for OT culture and cryopreservation included fibrin, alginate, collagen, hyaluronic acid, and extracellular matrix. Key preservation strategies involve encapsulating OT within biomaterial-based systems and enriching culture media with biomaterials. Hydrogels have demonstrated advantages by providing structural scaffolding and facilitating the diffusion of oxygen, nutrients, and bioactive supplements, thereby promoting angiogenesis and supporting OT functional restoration. Growing interest has focused on combinatorial approaches that integrate multiple biomaterials with stem cells, plasma proteins, and growth or antioxidant factors to enhance folliculogenesis and restore oestrous cycles. Despite progress, critical challenges persist, including capsule disintegration and the associated risk of immune sensitisation, as well as limited understanding of long-term tissue revascularisation and OT-biomaterial interactions. Overall, biobased materials strategies, particularly hydrogels, show promise for improving OT preservation and functionality, but further research is needed to optimise these materials and understand their long-term implications for fertility outcomes. Among the included studies, only one was a clinical study; the rest consisted of in vivo animal models and in vitro experiments. This limitation should be recognised, as it prevents direct application of the results to clinical practice. Consequently, further clinical research is crucial to confirm these strategies and facilitate their safe and effective implementation in fertility preservation protocols.

  • Open Access

    Targeting endometrial cancer stem cells through aldehyde dehydrogenase-mediated photodynamic therapy based on enhanced ring-fused chlorins

    by Beatriz Serambeque, Bruna Costa, Soraia Ferreira, Sofia Pinto Lopes, Marta Pineiro, Inês Dias, Susana M.M. Lopes, João C.S. Simões, Nelson A.M. Pereira, Raquel Alves, et al.

  • Open Access

    Photodynamic Therapy-Based Strategies Targeted at Cancer Stem Cells: A Scoping Review

    by Beatriz Serambeque, Inês Dias, Catarina Mestre, Carlos Miguel Marto, Maria Filomena Botelho, Maria João Carvalho, Mafalda Laranjo

    A major challenge in cancer treatment is the presence of cancer stem cells (CSC), which play a significant role in therapeutic resistance, metastatic progression, and tumor relapse, highlighting their importance as therapeutic targets. Photodynamic therapy (PDT) can be a valuable strategy for targeting CSC by increasing reactive oxygen species via light-activated photosensitizers, thereby counteracting CSC features of resistance. Therefore, this manuscript reviews the existing evidence on PDT-based approaches targeted at CSC. The literature search was conducted using the Medline (through PubMed), Web of Science, and Embase databases. The inclusion criteria were in vitro, in vivo, and clinical studies addressing PDT-based therapeutic strategies targeting CSC. A total of 37 publications were included in this review. From this analysis, we identified several studies with CSC-associated targets, delivery of PDT systems to CSC, novel nanoplatforms that disrupted the CSC microenvironment, and combined strategies to enhance PDT efficacy. The existing strategies have shown success in reducing CSC populations across different cancers by decreasing viability and tumor growth, as well as limiting stemness properties. However, some technical and biological constraints can limit translation, and, to the best of our knowledge, no clinical studies have been reported.